Colon Cancer Diagnostic Tests Market, by Test (FECAL OCCULT BLOOD TESTS (FOBT), BIOMARKER TESTS) and, by End User (Hospitals, CLINICAL DIAGNOSTIC LABORATORIES, PHYSICIANS’ OFFICE LABORATORIES, HOME TEST KIT): Global Opportunity Analysis and Industry Forecast, 2023-2032

• FECAL OCCULT BLOOD TESTS (FOBT)
• BIOMARKER TESTS

• Hospitals
• CLINICAL DIAGNOSTIC LABORATORIES
• PHYSICIANS’ OFFICE LABORATORIES
• HOME TEST KIT

• North America  (U.S., Canada, Mexico)
• Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
• Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
• LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)

Guardant Health, Inc., Biocartis Group NV, Quest Diagnostics Incorporated, Exact Sciences Corporation, Hologic, Inc., Roche Diagnostics, Cepheid Inc., Abbott Laboratories, Epic Sciences, Inc., Novartis AG